Sevelamer Carbonate Powder, For Suspension
Product Images NDC 72603-398

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 72603-398). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

333 (Sevelamer Carbonate Suspension Carton 90 Packets)

333 (Sevelamer Carbonate Suspension Carton 90 Packets)
FDA Label Image

222 (Sevelamer Carbonate Suspension Foil Label)

222 (Sevelamer Carbonate Suspension Foil Label)
FDA Label Image

Str (Sevelamer Figure 1)

Str (Sevelamer Figure 1)
FDA Label Image

Fig-2 (Sevelamer Figure 2)

Fig-2 (Sevelamer Figure 2)
FDA Label Image

Fig-1 (Sevelamer Figure 3)

Fig-1 (Sevelamer Figure 3)
This text appears to provide information about active control, serum phosphorus reduction, and specific values. The data seems to be related to some form of treatment or study, possibly focusing on reducing serum phosphorus levels. The text includes values and a description mentioning "Reduction from Baselir."*
FDA Label Image

Fig-4 (Sevelamer Figure 4)

Fig-4 (Sevelamer Figure 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.